EGRX
Eagle Pharmaceuticals Inc
Price:  
4.25 
USD
Volume:  
55,849.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGRX WACC - Weighted Average Cost of Capital

The WACC of Eagle Pharmaceuticals Inc (EGRX) is 8.0%.

The Cost of Equity of Eagle Pharmaceuticals Inc (EGRX) is 12.90%.
The Cost of Debt of Eagle Pharmaceuticals Inc (EGRX) is 5.00%.

Range Selected
Cost of equity 11.00% - 14.80% 12.90%
Tax rate 39.20% - 44.10% 41.65%
Cost of debt 4.60% - 5.40% 5.00%
WACC 7.0% - 9.1% 8.0%
WACC

EGRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.54 1.77
Additional risk adjustments 0.0% 0.5%
Cost of equity 11.00% 14.80%
Tax rate 39.20% 44.10%
Debt/Equity ratio 0.94 0.94
Cost of debt 4.60% 5.40%
After-tax WACC 7.0% 9.1%
Selected WACC 8.0%